Pancreatic cancer: Latest News, Top Stories & Analysis

PLYMOUTH MEETING, PA — New research in the September 2022 issue of JNCCN—Journal of the National Comprehensive Cancer Network finds the use of positron emission tomography (PET) with 18-fluorodeoxyglucose (FDG) tracer adds significant prognostic …

Products and Services

Panavance Therapeutics Announces Orphan Drug Designation for GP-2250

July 1, 2022July 1, 2022 - by MyChesCo

BERWYN, PA — Panavance Therapeutics Inc. announced the U.S. Food and Drug Administration (FDA) recently granted Orphan Drug Designation to GP-2250 for the treatment of all forms of pancreatic cancer.

Products and Services / Research

Panavance Therapeutics Announces Publication of Encouraging Preclinical Data Evaluating GP-2250

June 12, 2022June 12, 2022 - by MyChesCo

BERWYN, PA — Panavance Therapeutics Inc. announced the recent publication of positive data from a preclinical study evaluating GP-2250 for the treatment of pancreatic neuroendocrine carcinoma. The manuscript titled, “New …

Products and Services / Research

Aclaris Therapeutics Announces Publication of Preclinical Research of Zunsemetinib

December 4, 2021December 4, 2021 - by MyChesCo

WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) announced the recent publication of preclinical research of zunsemetinib in pancreatic cancer in the peer-reviewed journal Science Translational Medicine, on December 1, …